Celon Pharma SA Financial Overview
Celon Pharma SA's market cap is currently €1.02B. The company's EPS TTM is zł0.068; its P/E ratio is 62.24; and it has a dividend yield of 0.42%. Celon Pharma SA is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is zł―. See an overview of income statement, balance sheet, and cash flow financials.
